A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.

Colon cancer is one of the most common cancers in the U.S., with more than 100,000 cases diagnosed each year. But some people ...

Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...

Ziyafetova, G. (2026) Complete Response in Inoperable Stage IIB Squamous Cell Lung Carcinoma after Sequential Radiotherapy ...

Researchers discovered an antioxidant, glutathione, that cancer cells appear to be "addicted to" as fuel, opening new ...

Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...

This new type of immunotherapy shows promise for treating different cancers including prostate cancer, leukaemia and lung ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Men with aggressive prostate cancer, often left with few options after chemotherapy fails, now have access to a new treatment that uses a radioactive substance.The new treatment, Lutetium-177 PSMA ...

A UT Dallas and UT Southwestern study found tumors in younger patients develop in scar-like colon tissue — changes that may occur before cancer forms. Getty Images Last month, actor James Van Der Beek ...

Cancer is caused by faulty genes, but what also shapes a cancer cell's behavior is how a gene's instructions are trimmed and ...

Lyell Immunopharma, Inc. ( LYEL) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM EST ...